Akira Suda

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

Getnet Yimer, Wondwossen Amogne, Abiy Habtewold et al. · The Pharmacogenomics Journal · 2011 · 123 citations

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients

Getnet Yimer, Nobuhisa Ueda, Abiy Habtewold et al. · PLoS ONE · 2011 · 123 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

Eliford Ngaimisi, Sabina Mugusi, Omary Minzi et al. · Clinical Pharmacology & Therapeutics · 2010 · 106 citations

Medicine, Pharmacokinetics, Pharmacology +17

Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

Eliford Ngaimisi, Sabina Mugusi, Omary Minzi et al. · Clinical Pharmacology & Therapeutics · 2011 · 82 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients

Roza Ghotbi, Buster Mannheimer, Eleni Aklillu et al. · European Journal of Clinical Pharmacology · 2010 · 65 citations

Medicine, Genetics, Pharmacology +14